Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical Cancer Research

• Publication date

  2011-03-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-10-3377PMID 21447729
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combinatorial Control of Gene Expression

  2013cited by this paper
• Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer

  2010cited by this paper
• MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors.

  2010cited by this paper
• MET signalling: principles and functions in development, organ regeneration and cancer

  2010cited by this paper
• Molecular predictors of response to trastuzumab and lapatinib in breast cancer

  2010influential reference
• Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes

  2010cited by this paper
• MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis

  2009influential reference
• Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction

  2009cited by this paper
• Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer

  2009cited by this paper
• MACC1 controls Met: What a difference an Sp1 site makes

  2009cited by this paper
• The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer

  2009cited by this paper
• Drug development of MET inhibitors: targeting oncogene addiction and expedience

  2008cited by this paper
• 568 POSTER Selective inhibition of Met kinase activity impairs metastatic cancer cell motility and survival

  2008cited by this paper
• Urgent need for a new staging system in advanced colorectal cancer.

  2008cited by this paper
• Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients

  2008cited by this paper
• c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases.

  2008cited by this paper
• The cancer biomarker problem

  2008cited by this paper
• JNJ-38877605: a selective Met kinase inhibitor inducing regression of Met-driven tumor models.

  2008cited by this paper
• Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling

  2007cited by this paper
• Molecular targets and cancer therapeutics.

  2007cited by this paper
• aCGH local copy number aberrations associated with overall copy number genomic instability in colorectal cancer: coordinate involvement of the regions including BCR and ABL.

  2007cited by this paper
• Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome.

  2007cited by this paper
• Asymptomatic Colorectal Cancer with Un-Resectable Liver Metastases: Immediate Colorectal Resection or Up-Front Systemic Chemotherapy?

  2007cited by this paper
• Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752

  2006cited by this paper
• Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases

  2006cited by this paper
• Estimates of the cancer incidence and mortality in Europe in 2006.

  2006cited by this paper
• Combinatorial control of gene expression

  2004cited by this paper
• Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis

  2004cited by this paper
• c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases.

  2003cited by this paper
• Met, metastasis, motility and more

  2003cited by this paper
• Dysregulation of Met receptor tyrosine kinase activity in invasive tumors.

  2002cited by this paper
• Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma.

  1998cited by this paper
• Expression of c-met proto-oncogene in primary colorectal cancer and liver metastases.

  1997cited by this paper
• Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.

  1995cited by this paper
• Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor

  1992cited by this paper
• PATIENTS AND METHODS

  1980cited by this paper

• A Feasibility Study of Co-Established Patient-Derived Subcutaneous Xenograft and Organotypic Slice Cultures in Hormone-Naive Primary Prostate Cancer Preclinical Modeling: A Single-Institution Experience

  2025cites this paper
• Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer.

  2025cites this paper
• Saikosaponin-b2 Regulates the Proliferation and Apoptosis of Liver Cancer Cells by Targeting the MACC1/c-Met/Akt Signalling Pathway

  2024cites this paper
• Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer

  2024cites this paper
• Multi-label transcriptional classification of colorectal cancer reflects tumor cell population heterogeneity

  2023cites this paper
• Patient-Derived-Xenografts in Mice: A Preclinical Platform for Cancer Research.

  2023cites this paper
• mAb-Functionalized Biomimetic MamC-Mediated-Magnetoliposomes as Drug Delivery Systems for Cancer Therapy

  2023cites this paper
• Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer

  2023cites this paper
• The impacts of MACC1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan

  2023cites this paper
• MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities

  2023cites this paper
• Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarker

  2022cites this paper
• Inside the stemness engine: Mechanistic links between deregulated transcription factors and stemness in cancer.

  2022cites this paper
• IFN-γ affects pancreatic cancer properties by MACC1-AS1/MACC1 axis via AKT/mTOR signaling pathway

  2022cites this paper
• Elevated MACC1 Expression in Colorectal Cancer Is Driven by Chromosomal Instability and Is Associated with Molecular Subtype and Worse Patient Survival

  2022cites this paper
• Effect of MACC1 Genetic Polymorphisms and Environmental Risk Factors in the Occurrence of Oral Squamous Cell Carcinoma

  2021cites this paper
• A protocol for systematic review and meta-analysis

  2021cites this paper
• Examining the Role of the MACC1 Gene in Colorectal Cancer Metastasis

  2021cites this paper
• Preclinical models as patients’ avatars for precision medicine in colorectal cancer: past and future challenges

  2021cites this paper
• Colorectal Cancer: From Genetic Landscape to Targeted Therapy

  2021cites this paper
• High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer

  2020cites this paper
• Patient-derived xenograft models for personalized medicine in colorectal cancer

  2020cites this paper
• MiR-638 regulates gastric cardia adenocarcinoma cell proliferation, apoptosis, migration and invasion by targeting MACC1.

  2020cites this paper
• ArticleImplementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-

  2020cites this paper
• Decoding and targeting the molecular basis of MACC1-driven metastatic spread: lessons from big data mining and clinical-experimental approaches.

  2020cites this paper
• Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models

  2020cites this paper
• MET-dependent solid tumours — molecular diagnosis and targeted therapy

  2020cites this paper
• Immunohistochemical expression of insulin-like growth factor-1Ec in primary endometrial carcinoma: Association with PTEN, p53 and survivin expression

  2020cites this paper
• High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer

  2020cites this paper
• Typing, grading, and staging of cases of tumor

  2020cites this paper
• Modeling rectal cancer to advance neoadjuvant precision therapy

  2020cites this paper
• Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer

  2019cites this paper
• Examination of the expression levels of MACC1, Filamin A and FBXW7 genes in colorectal cancer patients

  2019cites this paper
• Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models

  2019cites this paper
• Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response

  2019cites this paper
• Evolving neoantigen profiles in colorectal cancers with DNA repair defects

  2019cites this paper
• Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts

  2019cites this paper
• Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours

  2019cites this paper
• MACC1 overexpression in carcinoma‑associated fibroblasts induces the invasion of lung adenocarcinoma cells via paracrine signaling.

  2019cites this paper
• Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer

  2019influential citation
• Correlation of MACC1/c-Myc Expression in Endometrial Carcinoma with Clinical/Pathological Features or Prognosis

  2018cites this paper
• Combined c-Met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in Glioblastoma.

  2018cites this paper
• Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice

  2018cites this paper
• Metastasis associated in colon cancer 1 ( MACC 1 ) : at the crossroads of cancer metastasis and drug resistanced

  2018cites this paper
• MACC1—the first decade of a key metastasis molecule from gene discovery to clinical translation

  2018cites this paper
• Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma

  2018cites this paper
• DBC1 regulates Wnt/β-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer

  2018cites this paper
• Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts

  2018cites this paper
• MACC1, a Novel Player in Solid Cancer Carcinogenesis

  2017cites this paper
• Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1

  2017cites this paper
• Crizotinib targets in glioblastoma stem cells

  2017cites this paper
• Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer

  2017cites this paper
• Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer

  2017cites this paper
• Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer

  2017cites this paper
• YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma

  2017cites this paper
• MACC 1 overexpression induces cisplatin resistance in lung adenocarcinoma A 549 cells by activating c-Met / Akt pathway

  2017cites this paper
• MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenon

  2016cites this paper
• The potential therapeutic applications and prognostic significance of metastasis-associated in colon cancer-1 (MACC1) in cancers

  2016cites this paper
• MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway

  2016cites this paper
• Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review

  2016cites this paper
• Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity

  2016cites this paper
• Patient-Derived Xenograft: An Adjuvant Technology for the Treatment of Metastatic Disease

  2016cites this paper
• SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival

  2016cites this paper
• The Analysis of Chromosome Amplification in Different Tumors

  2016influential citation
• SIGNIFICANCE OF SERUM HEPATOCYTE GROWTH FACTOR ( HGF ) AND ITS RECEPTOR CMET LEVELS IN COLORECTAL CANCER PATIENTS

  2016cites this paper
• Increased MACC1 expression indicates a poor prognosis independent of MET expression in gastric adenocarcinoma.

  2016cites this paper
• From Molecular Biology to Clinical Trials: Toward Personalized Colorectal Cancer Therapy.

  2016cites this paper
• 不同肿瘤染色体的扩增分析 The Analysis of Chromosome Amplification in Different Tumors

  2016cites this paper
• Metastasis-associated in colon cancer-1 in gastric cancer: Beyond metastasis.

  2016cites this paper
• Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.

  2016cites this paper
• Metastasis associated in colon cancer 1 (MACC1) promotes growth and metastasis processes of colon cancer cells.

  2016cites this paper
• MACC1 is post-transcriptionally regulated by miR-218 in colorectal cancer

  2016cites this paper
• FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion

  2015cites this paper
• Establishment of patient-derived cancer xenografts in immunodeficient NOG mice

  2015cites this paper
• Molecular Abnormalities in Tumors

  2015cites this paper
• IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies

  2015cites this paper
• Prognostic Value of MACC1 in Digestive System Neoplasms: A Systematic Review and Meta-Analysis

  2015cites this paper
• Aberrant expression of pim-3 promotes proliferation and migration of ovarian cancer cells.

  2015cites this paper
• The Genomic Landscape of Response to EGFR Blockade in Colorectal Cancer

  2015cites this paper
• Sustained Inhibition of HER 3 and EGFR Is Necessary to Induce Regression of HER 2-Ampli fi ed Gastrointestinal Carcinomas

  2015cites this paper
• Angularly resolved ellipsometric optical biosensing by means of Bloch surface waves

  2015cites this paper
• c-MET expression in colorectal adenomas and primary carcinomas with its corresponding metastases.

  2015cites this paper
• Targeting G-Quadruplex DNA Structures by EMICORON Has a Strong Antitumor Efficacy against Advanced Models of Human Colon Cancer

  2015cites this paper
• Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing.

  2014cites this paper
• Metastasis-associated colon cancer-1 is a novel prognostic marker for cervical cancer.

  2014cites this paper
• MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors.

  2014cites this paper
• Single Nucleotide Polymorphisms in the Metastasis-associated in Colon Cancer-1 Gene Predict the Recurrence of Hepatocellular Carcinoma after Transplantation

  2014cites this paper
• Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients.

  2014cites this paper
• Monoclonal Antibodies against the MET/HGF Receptor and Its Ligand: Multitask Tools with Applications from Basic Research to Therapy

  2014cites this paper
• 1 NOTCH 3 SIGNALING REGULATES MUSASHI-1 EXPRESSION IN METASTATIC COLORECTAL CANCER CELLS

  2014cites this paper
• MACC1 is involved in the regulation of proliferation, colony formation, invasion ability, cell cycle distribution, apoptosis and tumorigenicity by altering Akt signaling pathway in human osteosarcoma

  2014cites this paper
• Tumor and Stem Cell Biology NOTCH 3 Signaling Regulates MUSASHI-1 Expression in Metastatic Colorectal Cancer Cells

  2014cites this paper
• Analysis of HGF, MACC1, C-met and apoptosis-related genes in cervical carcinoma mice

  2014cites this paper
• Metastasis-Associated in Colon Cancer 1 Is a Novel Survival-Related Biomarker for Human Patients with Renal Pelvis Carcinoma

  2014cites this paper
• NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells.

  2014cites this paper
• MACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect

  2014cites this paper
• Anti-miR182 Reduces Ovarian Cancer Burden, Invasion, and Metastasis: An In Vivo Study in Orthotopic Xenografts of Nude Mice

  2014cites this paper
• MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients

  2014cites this paper
• Novel insights into MACC1 transcriptional regulation for identifying small molecule MACC1 inhibitors to restrict colorectal cancer progression

  2014cites this paper
• Mice Study in Orthotopic Xenografts of Nude In Vivo Metastasis : An Reduces Ovarian Cancer Burden , Invasion , and miR

  2014cites this paper
• MET-mediated resistance to EGFR inhibitors: an old liaison rooted in colorectal cancer stem cells.

  2014cites this paper